InsidersTradesSigma
Follow the 英科医疗 share price and the full directors' dealings record of the company, a listed equity based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 英科医疗 has published 10 insider filings. Market capitalisation: €32.9bn. The latest transaction was reported on 22 March 2024 (Purchase). Among the most active insiders: 刘方毅. The full history is accessible without an account.
10
Insider Decl.
n/a
Thresholds
€330,061
1 ops.
Buy Volume
€31m
9 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,798 of 28,835 companies
36.9
score / 100
Value36
Quality38
FCF yld-2.1%
Earn yld3.1%
EV/EBITDA19.6x
ROE3.8%
Gross mgn24%
Net mgn10%
Debt/EBITDA6.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 March 2024
Declarations10 total
10 of 10 declarations
About 英科医疗
英科医疗 is a company focused on the healthcare and pharmaceutical sector, providing medical products and healthcare solutions. It is listed on the XSHE market.